Quick Answer
BELITE BIO, INC reported Cash and Equivalents of $352.93 million for fiscal year 2025.
BELITE BIO, INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $352.93M | +1014.2% |
| 2024 | $31.68M | -64.1% |
| 2023 | $88.16M | +109.5% |
| 2022 | $42.09M | +142.7% |
| 2021 | $17.34M | — |
- BELITE BIO, INC showed an increase of +1014.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, BELITE BIO, INC’s cash and equivalents has grown by 1934.9% (from $17.34 million to $352.93 million).
- The most recent figure is from BELITE BIO, INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: